Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.

Since the first recorded infection of humans with H5N1 viruses of avian origin in 1997, sporadic human infections continue to occur with a staggering mortality rate of >60%. Although sustained human-to-human transmission has not occurred yet, there is a growing concern that these H5N1 viruses mig...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yasuko Hatta, Karen Hershberger, Kyoko Shinya, Sean C Proll, Richard R Dubielzig, Masato Hatta, Michael G Katze, Yoshihiro Kawaoka, M Suresh
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
Acceso en línea:https://doaj.org/article/6a1e8ec4b5164f69b12c6340dee70d21
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6a1e8ec4b5164f69b12c6340dee70d21
record_format dspace
spelling oai:doaj.org-article:6a1e8ec4b5164f69b12c6340dee70d212021-11-18T06:03:52ZViral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.1553-73661553-737410.1371/journal.ppat.1001139https://doaj.org/article/6a1e8ec4b5164f69b12c6340dee70d212010-10-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20949022/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Since the first recorded infection of humans with H5N1 viruses of avian origin in 1997, sporadic human infections continue to occur with a staggering mortality rate of >60%. Although sustained human-to-human transmission has not occurred yet, there is a growing concern that these H5N1 viruses might acquire this trait and raise the specter of a pandemic. Despite progress in deciphering viral determinants of pathogenicity, we still lack crucial information on virus/immune system interactions pertaining to severe disease and high mortality associated with human H5N1 influenza virus infections. Using two human isolates of H5N1 viruses that differ in their pathogenicity in mice, we have defined mechanistic links among the rate of viral replication, mortality, CD8 T cell responses, and immunopathology. The extreme pathogenicity of H5N1 viruses was directly linked to the ability of the virus to replicate rapidly, and swiftly attain high steady-state titers in the lungs within 48 hours after infection. The remarkably high replication rate of the highly pathogenic H5N1 virus did not prevent the induction of IFN-β or activation of CD8 T cells, but the CD8 T cell response was ineffective in controlling viral replication in the lungs and CD8 T cell deficiency did not affect viral titers or mortality. Additionally, BIM deficiency ameliorated lung pathology and inhibited T cell apoptosis without affecting survival of mice. Therefore, rapidly replicating, highly lethal H5N1 viruses could simply outpace and overwhelm the adaptive immune responses, and kill the host by direct cytopathic effects. However, therapeutic suppression of early viral replication and the associated enhancement of CD8 T cell responses improved the survival of mice following a lethal H5N1 infection. These findings suggest that suppression of early H5N1 virus replication is key to the programming of an effective host response, which has implications in treatment of this infection in humans.Yasuko HattaKaren HershbergerKyoko ShinyaSean C ProllRichard R DubielzigMasato HattaMichael G KatzeYoshihiro KawaokaM SureshPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 6, Iss 10, p e1001139 (2010)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Yasuko Hatta
Karen Hershberger
Kyoko Shinya
Sean C Proll
Richard R Dubielzig
Masato Hatta
Michael G Katze
Yoshihiro Kawaoka
M Suresh
Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.
description Since the first recorded infection of humans with H5N1 viruses of avian origin in 1997, sporadic human infections continue to occur with a staggering mortality rate of >60%. Although sustained human-to-human transmission has not occurred yet, there is a growing concern that these H5N1 viruses might acquire this trait and raise the specter of a pandemic. Despite progress in deciphering viral determinants of pathogenicity, we still lack crucial information on virus/immune system interactions pertaining to severe disease and high mortality associated with human H5N1 influenza virus infections. Using two human isolates of H5N1 viruses that differ in their pathogenicity in mice, we have defined mechanistic links among the rate of viral replication, mortality, CD8 T cell responses, and immunopathology. The extreme pathogenicity of H5N1 viruses was directly linked to the ability of the virus to replicate rapidly, and swiftly attain high steady-state titers in the lungs within 48 hours after infection. The remarkably high replication rate of the highly pathogenic H5N1 virus did not prevent the induction of IFN-β or activation of CD8 T cells, but the CD8 T cell response was ineffective in controlling viral replication in the lungs and CD8 T cell deficiency did not affect viral titers or mortality. Additionally, BIM deficiency ameliorated lung pathology and inhibited T cell apoptosis without affecting survival of mice. Therefore, rapidly replicating, highly lethal H5N1 viruses could simply outpace and overwhelm the adaptive immune responses, and kill the host by direct cytopathic effects. However, therapeutic suppression of early viral replication and the associated enhancement of CD8 T cell responses improved the survival of mice following a lethal H5N1 infection. These findings suggest that suppression of early H5N1 virus replication is key to the programming of an effective host response, which has implications in treatment of this infection in humans.
format article
author Yasuko Hatta
Karen Hershberger
Kyoko Shinya
Sean C Proll
Richard R Dubielzig
Masato Hatta
Michael G Katze
Yoshihiro Kawaoka
M Suresh
author_facet Yasuko Hatta
Karen Hershberger
Kyoko Shinya
Sean C Proll
Richard R Dubielzig
Masato Hatta
Michael G Katze
Yoshihiro Kawaoka
M Suresh
author_sort Yasuko Hatta
title Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.
title_short Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.
title_full Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.
title_fullStr Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.
title_full_unstemmed Viral replication rate regulates clinical outcome and CD8 T cell responses during highly pathogenic H5N1 influenza virus infection in mice.
title_sort viral replication rate regulates clinical outcome and cd8 t cell responses during highly pathogenic h5n1 influenza virus infection in mice.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/6a1e8ec4b5164f69b12c6340dee70d21
work_keys_str_mv AT yasukohatta viralreplicationrateregulatesclinicaloutcomeandcd8tcellresponsesduringhighlypathogenich5n1influenzavirusinfectioninmice
AT karenhershberger viralreplicationrateregulatesclinicaloutcomeandcd8tcellresponsesduringhighlypathogenich5n1influenzavirusinfectioninmice
AT kyokoshinya viralreplicationrateregulatesclinicaloutcomeandcd8tcellresponsesduringhighlypathogenich5n1influenzavirusinfectioninmice
AT seancproll viralreplicationrateregulatesclinicaloutcomeandcd8tcellresponsesduringhighlypathogenich5n1influenzavirusinfectioninmice
AT richardrdubielzig viralreplicationrateregulatesclinicaloutcomeandcd8tcellresponsesduringhighlypathogenich5n1influenzavirusinfectioninmice
AT masatohatta viralreplicationrateregulatesclinicaloutcomeandcd8tcellresponsesduringhighlypathogenich5n1influenzavirusinfectioninmice
AT michaelgkatze viralreplicationrateregulatesclinicaloutcomeandcd8tcellresponsesduringhighlypathogenich5n1influenzavirusinfectioninmice
AT yoshihirokawaoka viralreplicationrateregulatesclinicaloutcomeandcd8tcellresponsesduringhighlypathogenich5n1influenzavirusinfectioninmice
AT msuresh viralreplicationrateregulatesclinicaloutcomeandcd8tcellresponsesduringhighlypathogenich5n1influenzavirusinfectioninmice
_version_ 1718424608655278080